Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.22p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.50p
  • 52 Week Low: 0.075p
  • Currency: UK Pounds
  • Shares Issued: 1,207.03m
  • Volume: 18,701,821
  • Market Cap: £2.60m

Polarean Imaging signs distribution deal in South Korea

By Josh White

Date: Monday 24 Nov 2025

LONDON (ShareCast) - (Sharecast News) - Polarean Imaging announced the expansion of its Asia-Pacific footprint on Monday, by signing an exclusive distribution agreement with DK Healthcare for its Xenon MRI platform in South Korea, strengthening the company's international commercial strategy for its advanced lung-imaging technology.
The AIM-traded firm said the deal marked its second international distribution partnership, and positioned its hyperpolarised Xenon MRI system for entry into what it described as one of the world's most advanced medical-imaging markets.

It said it would work with DK Healthcare to secure the necessary regulatory approvals ahead of a commercial launch.

Polarean described DK Healthcare, an affiliate of DK, as a long-established provider of diagnostic radiology systems in South Korea.

Founded in 1986 and based in Seoul, the distributor works with global medical-device manufacturers and offers technical, clinical and maintenance support for imaging technologies.

"We are delighted to partner with DK Healthcare, one of South Korea's most respected medical imaging distributors, to expand access to our Xenon MRI platform," said Polarean chief executive Christopher von Jako.

"South Korea's strong emphasis on early detection and precision medicine makes it an ideal growth market, and this agreement accelerates our dual-track strategy to grow internationally through high-quality regional partners while our US team continues to drive adoption domestically."

DK Healthcare chief executive Joonhyuk Lee said the distributor was "excited to introduce Polarean's Xenon MRI technology to Korea's leading hospitals and imaging centers."

"This platform offers clinicians a new dimension in lung function assessment by enabling visualisation of ventilation and gas-exchange that was previously impossible with conventional imaging.

"We believe Xenon MRI will play a vital role in transforming respiratory care in South Korea through enhancing early detection and outcomes for patients with lung cancer, COPD and beyond."

At 1227 GMT, shares in Polarean Imaging were up 0.59% at 0.09p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

POLX Market Data

Currency UK Pounds
Share Price 0.22p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.50p
52 Week Low 0.075p
Volume 18,701,821
Shares Issued 1,207.03m
Market Cap £2.60m

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

POLX Dividends

No dividends found

Trades for 09-Dec-2025

Time Volume / Share Price
12:40 2,500,000 @ 0.21p
12:30 50,000 @ 0.21p
12:04 500,000 @ 0.21p
11:51 312,820 @ 0.21p
11:46 2,500,000 @ 0.21p

POLX Key Personnel

CFO Charles Osborne
CEO Christopher von Jako

Top of Page